|
Issues and Threats Facing the Biotechnology Industry (May 23, 2007)
BIO President and CEO, Jim Greenwood, appeared on PharmaTelevision where he discusses the challenges facing the industry today, covering topics such as the impacts of the Democrat majority in the US, public perception of the industry, the recent trends in outsourcing, and Jim's vision for the future.
Watch the video
Biotech Fashion Show (July 2006)
A fashion show at the recent World Congress on Industrial Biotechnology and Bioprocessing featured both ready-to-wear clothing and designer gowns -- including some made by top fashion designers Halston, Oscar de la Renta, Stephen Burrows, Heatherette, and Elisa Jimenez -- made with IngeoTM fabric. IngeoTM is spun from polylactide (PLA), a compostable biopolymer made from dextrose corn sugar that is fermented in a biotech process. The fashion show highlighted the diversity of biobased products made with industrial biotechnology currently available to consumers, including plastics, food ingredients, and fuels.
Watch the video (WMV 8 min.)
April 10, 2006
From Food to Fuel to Fashion
BIO 2006 Features Consumer Products Made With Industrial Biotechnology
Presentation Description, Photos, and Video
Feb. 10, 2006
2005 Global Biotech Crop Acreage Increases
September 9, 2005
BIO Releases Statement on Animal Rights Extremists and NYSE
Read Jim Greenwood's statement
Read Jim Greenwood's letter to the NYSE (PDF)
September 2005
Many BIO members donated to the hurricane relief efforts.
See the list
April 2005
Technology Times Cover Story with BIO President James Greenwood
Read the interview (664 KB PDF)
April 19-20, 2005
BIO Legislators of the Year 2005
March 2005
Pharmaceutical Executive Interview with BIO President James Greenwood
Read the interview (304 KB PDF)
Feb. 22 2005
BIO Opens NASDAQ
Jan. 2005
BIO Members Help Tsunami Victims
Aug. 2004
BIO 2004: BIO Board Members Headline BIO TV
Mar. 2004
How Industrial Biotechnology Can Help Consumers and the Environment
Jan. 2004
Q&A with BIO Ag Chair Richard Hamilton
Jan. 2004
Bioethics—Reassuring a Not-So-Brave New World
Jan. 16, 2004
BIO Sends 2004 Priorities to President Bush (192 KB PDF)
Jan. 13, 2004
Global Biotech Crop Acreage Increases
Jan. 2004
The Measures of Biotechnology Success: Beyond Wall Street
Dec. 2003
Bedeviling Details: BIO Pursues Legislative Corrections
Nov. 2003
New Obesity Drugs Move Closer to the Market
Nov. 2003
Former U.S. President Carter Backs Biotechnology For Africa
Oct. 2003
VCs Seeking Clinical Products, Cautious About Platforms
Oct. 27, 2003
"Today Show" Features Foods Improved Through Biotechnology
Oct. 2003
Q&A With Richard Pops: Medicare, FDA Issues Top New Chairman's Agenda
Oct. 2003
 Energy Future Coalition Recognizes the Vital Role of Biotechnology in Energy Production
Sep. 2003
BIO President Carl B. Feldbaum on the Intersection of Chemistry & Biotechnology
Aug./Sep., 2003
European Biotech Blockade Moves to Int'l. Court from BIO News, a member publication
Aug./Sep., 2003
Industry Reporters Predict Biotech PR Hurdles Over the Next 10 Years from BIO News, a member publication
July 16, 2003
BIO Issue Brief on Biosafety Protocol
June 30, 2003
June 20, 2003
President Bush to Speak at BIO 2003
June 16, 2003
BIO 2003 Convention Draws Worldwide Media Attention to Global Impact of Science Industry
June 13, 2003
BIO Calls Senate Committee's OPPS Measure an Excellent First Step
June 10, 2003
June 9, 2003
 |
Banking on Biotech (213 KB PDF)
A special advertising section reprinted from the June 9 issue of Fortune. |
May 13, 2003
United States files WTO case against EU
WTO Background Information
Apr. 24
BIO Calls on FDA To Conduct Open, Public Discussion on Follow-on Biologics
April 7, 2003
Biotech Executives to Tell Congress: Fix OPPS With Proposed Legislative Remedies
BIO/CHI Hill Briefing on CMS (ISDN RealVideo)
Patient Access at Risk (56k RealVideo) (Apr. 2)
April, 2003
 |
The DNA Revolution
Fifty Years after Watson and Crick, the New Questions in Genetics - From NPR. |
March 27, 2003
BIO Testimony on Project BioShield
March, 2003
February 21, 2003
February, 2003
News from the Future of Life Summit
Day 3: Living to 1000? (Feb. 21, 2003)
Day 2: Tough Questions, No Easy Answers (Feb. 21, 2003)
Live from the Future of Life (Feb. 20, 2003)
The Ghost of Old Doc Ricketts (Feb. 19, 2003)
February 6, 2003
BIO's Analysis of Bush's Budget
BIO Sends Industry Agenda for 2003 to President Bush
February 5, 2003
BIO Statement: Anti-Cloning Bill Deserves Support
February 3, 2003
Biotechs Scored 23 Product Approvals In 2002, Including 9 New Therapies
From Signals by Jennifer Van Brunt
February-March, 2003
January 29, 2003
BIO Calls for Restoration of Medicare Drug Coverage
BIO Testimony on Medicare Restoration (PDF)
January 24, 2003
New BIO Science and Regulatory Department to be headed by Dr. Gillian R. Woollett
January 24, 2003
The Year of the Bear
From Signals by Jennifer Van Brunt
December 18, 2002
Medicare Patients Face a New Year With Yesterday's Medicines
Statement Regarding Plants That Produce Pharmaceutical and Industrial Products
December, 2002
December, 2002
 |
Financing in a down market
'When will biotech come back?', and, 'what type of biotech companies will succeed?' and 'where do biotechs go for cash?' - From Biotechnology Investors' Forum. |
November 25, 2002
E&Y: Biotech Reaches Globally For Financing And Opportunity
From BIOWorld Online by Karen Pihl-Carey
November 24, 2003
Medicon Valley Developing R&D Capabilities, Attracting Attention
From BIOWorld Online by Cormac Sheridan
Nov. 14, 2002
BIO President Carl B. Feldbaum addresses BioIreland on U.S. Biotechnology Trends
Nov. 5, 2002
Gates Foundation, BIO Global Health Forum Features International Health Experts
November 4, 2002
New Nucleoside Analogue, Drug Combos Promising In Leukemia
From BIOWorld Online by Randall Osborne
October 30, 2002
 |
The Placebo Effect
Market forces, product difficulties and delays have driven down stock prices, dried up cash reserves and compelled many biotech firms to tighten their belts - From Signals Magazine. |
Sep. 24, 2002
Transgenic Animals
Fact Sheet, Myths, and Other Resources
Sep. 20, 2002
The Application of Industrial Biotechnology to Pollution Prevention
A New Slide Show. Download the PowerPoint Presentation (2 MB)
Sep. 6, 2002
FDA Streamlining of Biopharmaceutical Review A Welcome Development
September, 2002
Stocks Are Down, Financing Up This summer was like early 1999 all over again... the last time the Nasdaq Biotech Index slipped below 500.
Jul. 11, 2002
Bioethics Council Split Illustrates Support for Research
Jun. 28, 2002
BIO Supports Medicare Prescription Drug Coverage
Jun. 12, 2002
BIO Announces 2002-2003 Board of Directors
May 30, 2002
BIO and NASA - Expanding Biotech Cooperation in Space
May 22, 2002
House Passes Bioterrorism/PDUFA Legislation in 425-1 Vote
PDUFA Changes Minor (PDF Summary);
Bioterrorism Legislation 'A Good First Step'
May 21, 2002
122 Biotech CEOs Call for FDA Commissioner
BIO Member CEOs Sign Letter to President Bush
Mar. 6, 2002
BIO Urges PDUFA Reauthorization
House Subcommittee Hears Testimony from BIO Member on Prescription Drug User Fee Act
March 3, 2002
BIO's New TV Ad, "DNA", premiered. View the Ad.
Feb. 28, 2002
BIO Names Two to Board
Genentech's Susan Desmond-Hellmann and
Amgen's Dennis Fenton, New Board Members
Feb. 22, 2002
Carl B. Feldbaum and BIO CEOs Open The Nasdaq Stock Market. Feb 22 at Nasdaq's MarketSite in New York City. More Pictures *
Feb. 21, 2002
Two Companies Awarded 2002 Helix Award for Corporate Excellence
BIO Statement on NAS Report on Transgenic Plants
Feb. 20, 2002
 BIO, E&Y Lead Private Sector Initiative to Provide Biotechnology Resources for the Federal Judiciary. Preview the web site. Press release.
Feb. 8, 2002
CBS News Features Industrial Biotech
"Using Biotechnology, Scientists Are Making Eco-Friendly Products"
Proposed Hike in User Fees Unfair Burden for Biotech Companies
Feb. 6, 2002
USDA: Bt Corn Not a Threat to Monarch Butterfly
A consortium of federal, university and industry scientists led by the Agricultural Research Service has completed two years of research to answer the question: Does Bt corn pose a threat to monarch butterflies? The answer, supported by science, is that there is no significant risk.
Feb. 5, 2002
Board Member Testifies In Senate Hearing
Meeting the Bioterrorism Threat with Cooperation Between the Federal Government and Biotechnology Industry.
Jan. 30, 2002
BIO 2002 Media Registration Opens
Jan. 18, 2002
BIO Supports NAS Findings
Supports ban on human reproductive cloning and continued stem cell research.
Jan. 16, 2002
BIO Sends Industry Agenda for 2002 to President Bush
Dec. 19, 2001
CMS Delays OPPS Payment Cuts For Breakthrough Medicines
Centers for Medicare and Medicaid Services postpone implementation by at least three months.
Nov. 29, 2001
OPPS Cut Harms Patients, Defies Congressional Intent
Centers for Medicare and Medicaid Services slash payments for innovative medications.
Nov. 25, 2001
BIO Opposed to Reproductive Cloning;
Supports Therapeutic Applications.
Nov. 16, 2001
BIO-Europe 2001 Sets Attendance Record
Over 1,000 Executives & Investors came to Munich.
Nov. 14, 2001
Dispatch from BIO-Europe
In addition to 135 formal business-plan presentations, more than 1,250 private partnering meetings had been scheduled as of this morning, the last day of the conference.
Nov. 13, 2001
Dispatch from BIO-Europe
More than 1,000 pharmaceutical and biotechnology players have come to Munich for BIO-Europe.
Nov. 5, 2001
Statement on Ethical Use of Biotechnology
to Promote Public Health and National Security and to Fight Against Bioterrorism.
Oct. 24, 2001
Biotechnology, Public Health, and National Security
How the industry can develop biodefense products.
Oct. 23, 2001
Biological Warfare Defense Vaccine Research & Development Programs
Congressional Hearing testimony from BIO members.
Oct. 16, 2001
EPA Decision Reconfirms Safety of Modified Corn
Benefits for Growers and the Environment Also Supported by Recent Report. After almost two years of thorough scientific review and debate, EPA today approved Bt corn registrations for seven additional years after determining , "... [Bt corn] does not pose risks to human health or to the environment." The Agency also specified that extensive evidence demonstrates that Bt corn poses no danger to the Monarch butterfly populations. EPA 's decision is the final installment of a comprehensive reassessment of the registrations for all commercialized Bt plant-incorporated protectants. During the reassessment process, the Agency debated whether to extend or to amend additional considerations to the registrations such as insect resistance management and the protection of non-target organisms to ensure public and environmental safety. "The EPA's approval of continued use for these products sends a strong signal to the rest of the world that these products are safe and offer significant benefits for growers, consumers and the environment," said Val Giddings, BIO vice president for food and agriculture.
Oct. 11, 2001
EU Report Finds Modified Crops Safe
"... even safer than conventional plants and foods." An Oct. 9 report from the European Commission on the crops and plants improved through biotechnology states that "the use of more precise technology and the greater regulatory scrutiny probably make them even safer than conventional plants and foods." The report is comprised of over 15 years of research and summarizes the 81 projects, which have received a total EU-funding of € 70 million and have involved over 400 scientific teams from all parts of Europe.
Oct. 08, 2001
Supreme Court Considers Plant Patents
BIO files brief supporting patent claims.
Focus on Fundamentals: A Biotech Report
Ernst & Young reports that the biotech sector is in its best financial shape ever.
Bt Cotton Passes EPA Reassessment
"...Bt cotton will not pose unreasonable risks to human health or to the environment." EPA has extended Bt cotton registrations through September 30, 2006, after determining that, "...there is reasonable certainty that Bt cotton will not pose unreasonable risks to human health or to the environment." EPA's decision is part of a comprehensive reassessment of the time-limited registrations for all commercialized Bt plant-incorporated protectants. During the reassessment process, the Agency will decide whether to extend the registrations and whether to include any additional considerations such as insect resistance management and the protection of non-target organisms to ensure public and environmental safety. Bt corn registrations are next on EPA's reassessment docket with a decision expected the end of the month.
Oct. 01, 2001
BT Crops Pose Little Risk to Monarch Butterflies
Proceedings of the National Academy of Sciences Publish Six New Papers
Entrepreneurs, Venture Capitalists Gather at BIO VentureForum 2001
Washington Hosts Unprecedented International Gathering
| 
